# FBLG (FibroBiologics, Inc.) - SEC EDGAR Financial Statements

> FibroBiologics, Inc. reported $6.75M in total assets and a net loss of $16.41M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/FBLG
- Markdown: https://convexityos.com/fundamentals/FBLG.md
- SEC CIK: 0001958777
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001958777&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$15.76M | Operating profit |
| Net Income | FY 2025 | -$16.41M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.55 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$13.59M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $1.17M | Total debt: $1.27M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Research & Development | $7.41M | $4.50M | $2.37M | $1.15M |
| Total Operating Expenses | $16.65M | $13.74M | $8.89M | $4.47M |
| **Operating Income** | -$16.65M | -$13.74M | -$8.89M | -$4.47M |
| **EBITDA** | -$16.41M | -$13.58M | -$8.84M | -- |
| Interest Income | $247K | $251K | -- | -- |
| Interest Expense | $204K | $20K | $147K | $654K |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| **Net Income** | -$18.65M | -$11.16M | -$16.48M | -$5.12M |
| Basic EPS | -$8.40 | -$6.80 | -$13.60 | -$3.60 |
| **Diluted EPS** | -$8.40 | -$6.80 | -$13.60 | -$3.60 |
| Basic Shares Outstanding | 2.2M | 1.6M | 1.4M | 1.4M |
| Diluted Shares Outstanding | 2.2M | 1.6M | 1.4M | 1.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.08M | $1.66M | $2.95M | $797K | $2.79M | $2.04M | $1.78M | $1.36M |
| Total Operating Expenses | $4.07M | $4.03M | $5.07M | $2.59M | $5.04M | $4.49M | $4.53M | $3.71M |
| **Operating Income** | -$4.07M | -$4.03M | -$5.07M | -$2.59M | -$5.04M | -$4.49M | -$4.53M | -$3.71M |
| **EBITDA** | -$4.00M | -$3.97M | -$5.00M | -$2.52M | -$4.97M | -$4.43M | -$4.48M | -$3.67M |
| Interest Income | $20K | $15K | $20K | $25K | $73K | $50K | $99K | $63K |
| Interest Expense | $4.0K | $7.0K | $4.0K | $204K | $0 | $0 | $0 | $6.0K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | -$4.05M | -$4.12M | -$5.00M | -$3.24M | -$5.78M | -$4.66M | -$4.97M | -$3.10M |
| Basic EPS | -$0.38 | -$0.66 | -$1.33 | -- | -$2.68 | -$2.41 | -$2.71 | -- |
| **Diluted EPS** | -$0.38 | -$0.66 | -$1.33 | -- | -$2.68 | -$2.41 | -$2.71 | -- |
| Basic Shares Outstanding | 10.6M | 6.3M | 3.8M | -- | 2.2M | 1.9M | 1.8M | -- |
| Diluted Shares Outstanding | 10.6M | 6.3M | 3.8M | -- | 2.2M | 1.9M | 1.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.89M | $13.98M | $9.16M | $2.27M |
| **Cash & Short-Term Investments** | $4.89M | $13.98M | $9.16M | $2.27M |
| Accounts Receivable, Net | -- | -- | -- | $300K |
| Other Current Assets | $0 | $18K | $16K | $30K |
| **Total Current Assets** | $6.35M | $14.23M | $9.21M | $2.62M |
| Property, Plant & Equipment, Net | $842K | $824K | $797K | -- |
| **Total Non-Current Assets** | $3.27M | $2.22M | $2.61M | $2.20M |
| **Total Assets** | $9.62M | $16.45M | $11.82M | $4.82M |
| **Total Current Liabilities** | $1.76M | $12.73M | $9.18M | $7.07M |
| **Total Non-Current Liabilities** | $1.70M | $984K | $1.39M | $1.75M |
| **Total Liabilities** | $3.46M | $13.71M | $10.57M | $8.82M |
| **Total Debt (incl. Leases)** | $2.41M | $1.39M | $1.75M | $2.07M |
| Common Stock | $1.0K | $0 | -- | $10.00M |
| Retained Earnings | -$54.16M | -$35.52M | -$24.36M | -$7.87M |
| **Total Stockholders' Equity** | $6.16M | $2.73M | $1.25M | -$4.00M |
| Total Equity | $6.16M | $2.73M | $1.25M | -$4.00M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.17M | $3.52M | $1.48M | $4.89M | $4.87M | $8.85M | $8.67M | $13.98M |
| **Cash & Short-Term Investments** | $1.17M | $3.52M | $1.48M | $4.89M | $4.87M | $8.85M | $8.67M | $13.98M |
| Other Current Assets | -- | -- | $403K | $0 | -- | -- | $18K | $18K |
| **Total Current Assets** | $4.78M | $5.85M | $2.90M | $6.35M | $5.24M | $10.18M | $9.33M | $14.23M |
| Property, Plant & Equipment, Net | $661K | $710K | $776K | $842K | $908K | $967K | $814K | $824K |
| **Total Non-Current Assets** | $1.97M | $2.08M | $3.03M | $3.27M | $3.50M | $3.73M | $2.10M | $2.22M |
| **Total Assets** | $6.75M | $7.93M | $5.94M | $9.62M | $8.74M | $13.91M | $11.43M | $16.45M |
| **Total Current Liabilities** | $3.93M | $2.21M | $1.83M | $1.76M | $6.72M | $10.96M | $8.21M | $12.73M |
| **Total Non-Current Liabilities** | $1.01M | $1.08M | $1.51M | $1.70M | $1.90M | $2.08M | $865K | $984K |
| **Total Liabilities** | $4.94M | $3.29M | $3.34M | $3.46M | $8.62M | $13.05M | $9.08M | $13.71M |
| **Total Debt (incl. Leases)** | $1.27M | $1.34M | $2.23M | $2.41M | $2.54M | $2.71M | $1.28M | $1.39M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | -- | $0 |
| Retained Earnings | -$67.33M | -$63.28M | -$59.16M | -$54.16M | -$50.92M | -$45.14M | -$40.48M | -$35.52M |
| **Total Stockholders' Equity** | $1.81M | $4.64M | $2.60M | $6.16M | $125K | $860K | $2.35M | $2.73M |
| Total Equity | $1.81M | $4.64M | $2.60M | $6.16M | $125K | $860K | $2.35M | $2.73M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$18.65M | -$11.16M | -$16.48M | -$5.12M |
| Depreciation & Amortization | $244K | $157K | $47K | -- |
| Stock-Based Compensation | $2.69M | $2.22M | $1.76M | $265K |
| **Operating Cash Flow** | -$16.39M | -$11.90M | -$6.40M | -$4.07M |
| Capital Expenditure | -$262K | -$184K | -$495K | -- |
| **Free Cash Flow** | -$16.66M | -$12.09M | -$6.90M | -- |
| **Investing Cash Flow** | -$262K | -$184K | -$495K | -- |
| Common Stock Issued | $6.59M | $7.51M | $16.42M | -- |
| **Financing Cash Flow** | $7.57M | $16.91M | $13.79M | $5.92M |
| **Net Change in Cash** | -$9.09M | $4.82M | $6.90M | $1.86M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$4.05M | -$4.12M | -$5.00M | -$3.24M | -$5.78M | -$4.66M | -$4.97M | -$3.10M |
| Depreciation & Amortization | $66K | $66K | $66K | $66K | $65K | $60K | $53K | $47K |
| Stock-Based Compensation | $671K | $707K | $694K | $702K | $704K | $729K | $551K | $544K |
| **Operating Cash Flow** | -$2.75M | -$3.29M | -$4.36M | -$3.16M | -$3.97M | -$3.98M | -$5.28M | -$3.07M |
| Capital Expenditure | -$18K | $0 | $0 | $0 | -$6.0K | -$213K | -$43K | -$99K |
| **Free Cash Flow** | -$2.77M | -$3.29M | -$4.36M | -$3.16M | -$3.98M | -$4.20M | -$5.32M | -$3.17M |
| **Investing Cash Flow** | -$18K | $0 | $0 | $0 | -$6.0K | -$213K | -$43K | -$99K |
| Common Stock Issued | $550K | $2.86M | $706K | $6.59M | $0 | $0 | $0 | $45K |
| **Financing Cash Flow** | $426K | $5.32M | $952K | $3.19M | $0 | $4.38M | $0 | $9.33M |
| **Net Change in Cash** | -$2.35M | $2.03M | -$3.41M | $27K | -$3.98M | $178K | -$5.32M | $6.16M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -302.9% | -408.1% | -1315.6% | -- |
| Return on Assets (ROA) | -193.8% | -67.9% | -139.5% | -106.2% |
| Current Ratio | 3.61x | 1.12x | 1.00x | 0.37x |
| Quick Ratio | 2.78x | 1.10x | 1.00x | 0.36x |
| Debt to Equity | 0.39x | 0.51x | 1.39x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -907.1% | -391.3% | -718.5% | -302.9% | -14800.8% | -1537.6% | -326.3% | -408.1% |
| Return on Assets (ROA) | -243.1% | -228.8% | -314.6% | -193.8% | -211.6% | -95.1% | -67.1% | -67.9% |
| Current Ratio | 1.22x | 2.64x | 1.59x | 3.61x | 0.78x | 0.93x | 1.14x | 1.12x |
| Quick Ratio | 0.30x | 1.59x | 0.81x | 2.78x | 0.72x | 0.81x | 1.06x | 1.10x |
| Debt to Equity | 0.70x | 0.29x | 0.86x | 0.39x | 20.32x | 3.15x | 0.54x | 0.51x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -618.7% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -501.7% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
